References
- Sampalo A, Brieva J A. Humoral immunodeficiency in chronic lymphocytic leukemia: role of CD95/CD95L in tumoral damage and escape. Leuk Lymphoma 2002; 43: 881–884
- Scrivener S, Goddard R V, Kaminski E R, Prentice A G. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. Leuk Lymphoma 2003; 44: 383–389
- Mercadal S, Martinez A, Nomdedeu B, Rozman M, Gaya A, Salamero O, et al. Herpes simplex and Epstein–Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine. Eur J Haematol 2006; 77: 442–444
- Joseph L, Scott M A, Schichman S A, Zent C S. Localized herpes simplex lymphadenitis mimicking large-cell (Richter's) transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 2001; 68: 287–291
- Dasanu C A, Alexandrescu D T. Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia. Med Gen Med 2007; 9: 35
- Molica S. Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different therapies. Leuk Lymphoma 2005; 46: 49–54
- Sampalo A, Navas G, Medina F, Segundo C, Camara C, Brieva J A. Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction. Blood 2000; 96: 3168–3174
- Arens R, Nolte M A, Tesselaar K, Heemskerk B, Reedquist K A, van Lier R A, et al. Signaling through CD70 regulates B cell activation and IgG production. J Immunol 2004; 173: 3901–3908
- Perri R T, Kay N E. Abnormal T cell function in early-stage chronic lymphocytic leukemia (CLL) patients. Am J Hematol 1986; 22: 55–61